| Drug Name: | Succinylcholine (306-40-1) |
|---|---|
| PubChem ID: | 5314 |
| SMILES: | C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C |
| InchiKey: | AXOIZCJOOAYSMI-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 290.404 |
| LogP | : | 0.2654 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 52.6 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Aprotinin (9087-70-1) | Apnoea | Antagonistic | Not Understood | Influence of aprotinin (Trasylol) on the action of suxamethonium |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Apnoea | Cholinesterase precursor (P06276) | Prolonged apnoea [ ADR Type 1 ] | Drugs in special patient groups: clinical importance of genomics in drug effects In: Carruthers GS, Hoffmann BB,Melmon KL, Nierenberg DW |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category